Trial site
CenExel Rocky Mountain Clinical Research
- 9running trials
- 7closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Parkinson disease7 trials
- Alzheimer disease6 trials
- Dystonia1 trial
- Huntington's disease1 trial
- Lewy body dementia1 trial
- Mild cognitive impairment1 trial
- Multiple system atrophy1 trial
- Phase
- Phase 28 trials
- Phase 2/33 trials
- Phase 33 trials
- Phase 1/21 trial
- Status
- Active, not recruiting6 trials
- Completed5 trials
- Recruiting2 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Annovis Bio Inc.3 trials
- Eli Lilly and Company2 trials
- Ono Pharmaceutical Co., Ltd.2 trials
- Alexza Pharmaceuticals, Inc.1 trial
- AriBio Co., Ltd.1 trial
- and 7 more
Running trials
Not yet recruiting
An Open-label Long-term Safety Study of Buntanetap in Participants With AD
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Recruiting
Active, not recruiting
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
Active, not recruiting
A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Lewy body dementia1 recruiting
- Mild cognitive impairment1 recruiting
- Parkinson disease1 recruiting
Closed trials
Completed
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
Terminated
Terminated
Completed
Completed
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026